[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 116, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1635958, "exercisedValue": 0, "unexercisedValue": 3699450}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 51, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 943077, "exercisedValue": 0, "unexercisedValue": 1056212}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 45, "title": "General Counsel & Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 816300, "exercisedValue": 0, "unexercisedValue": 860184}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 49, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Spar", "title": "Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 269.26, "open": 271.65, "dayLow": 267.54, "dayHigh": 279.14, "regularMarketPreviousClose": 269.26, "regularMarketOpen": 271.65, "regularMarketDayLow": 267.54, "regularMarketDayHigh": 279.14, "payoutRatio": 0.0, "beta": 2.975, "forwardPE": -21.60355, "volume": 1033202, "regularMarketVolume": 1033202, "averageVolume": 1047631, "averageVolume10days": 792170, "averageDailyVolume10Day": 792170, "bid": 196.74, "ask": 338.84, "bidSize": 2, "askSize": 2, "marketCap": 6824957952, "fiftyTwoWeekLow": 26.7, "fiftyTwoWeekHigh": 282.99, "allTimeHigh": 914.265, "allTimeLow": 11.85, "priceToSalesTrailing12Months": 914.506, "fiftyDayAverage": 190.95, "twoHundredDayAverage": 80.14548, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6558236160, "profitMargins": 0.0, "floatShares": 20522135, "sharesOutstanding": 25007171, "sharesShort": 3550804, "sharesShortPriorMonth": 3058291, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.142, "heldPercentInsiders": 0.00182, "heldPercentInstitutions": 0.96152, "shortRatio": 3.94, "shortPercentOfFloat": 0.14220001, "impliedSharesOutstanding": 25007171, "bookValue": 16.229, "priceToBook": 16.81681, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -273036000, "trailingEps": -12.96, "forwardEps": -12.63311, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 878.767, "enterpriseToEbitda": -22.387, "52WeekChange": 2.5183704, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 272.92, "targetHighPrice": 760.0, "targetLowPrice": 83.0, "targetMeanPrice": 419.13333, "targetMedianPrice": 420.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 15, "totalCash": 267156992, "totalCashPerShare": 10.683, "ebitda": -292951008, "totalDebt": 436000, "quickRatio": 5.052, "currentRatio": 5.178, "totalRevenue": 7463000, "debtToEquity": 0.127, "revenuePerShare": 0.353, "returnOnAssets": -0.45086, "returnOnEquity": -0.75198996, "grossProfits": -238434000, "freeCashflow": -133374752, "operatingCashflow": -228864992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -39.27509, "financialCurrency": "USD", "symbol": "PRAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Praxis Precision Medicines, Inc", "corporateActions": [], "postMarketTime": 1766189913, "regularMarketTime": 1766178001, "exchange": "NMS", "messageBoardId": "finmb_409236524", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Praxis Precision Medicines, Inc.", "fiftyTwoWeekLowChange": 246.22002, "fiftyTwoWeekLowChangePercent": 9.221724, "fiftyTwoWeekRange": "26.7 - 282.99", "fiftyTwoWeekHighChange": -10.069977, "fiftyTwoWeekHighChangePercent": -0.035584215, "fiftyTwoWeekChangePercent": 251.83704, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "earningsCallTimestampStart": 1754310600, "earningsCallTimestampEnd": 1754310600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -12.96, "epsForward": -12.63311, "epsCurrentYear": -13.10658, "priceEpsCurrentYear": -20.82313, "fiftyDayAverageChange": 81.97002, "fiftyDayAverageChangePercent": 0.42927477, "twoHundredDayAverageChange": 192.77454, "twoHundredDayAverageChangePercent": 2.4053078, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": 1.35928, "regularMarketPrice": 272.92, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "postMarketChangePercent": 0.91967577, "postMarketPrice": 275.43, "postMarketChange": 2.5099792, "regularMarketChange": 3.66, "regularMarketDayRange": "267.54 - 279.14", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1047631, "displayName": "Praxis Precision Medicines", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]